Jason Goldberg is ranked #138 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Jason Goldberg (Barclays) — Analyst Ratings, Accuracy & Track Record

Q: How accurate are Jason Goldberg's stock ratings?

About 73% of Jason's ratings were profitable over a one-year hold, with an average return of +10.1% per rating, measured by 13Foresight from historical prices.

Analyst Tracker/Jason Goldberg

BARC

Jason Goldberg

Barclays

Wall Street Analyst

★★★★★

#138

on 13Foresight · ranked by our own returns

73%

Success Rate

+10.1%

Average Return

43 of 59 calls profitable · +5.7% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

📈 Across the calls we could measure, roughly 73% of Jason Goldberg's ratings turned a profit when each position was held for 1 year — averaging +10.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

156 Buy 105 Hold 45 Sell

Jason's Stock Coverage 34 ratings · 2026-07-17

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return
PNC PNC Financial	Jul 16, 2026	BUY	Strong Buy +0.4% avg upside 28 analysts	$284.00 11.33% Upside	·
MS Morgan Stanley	Jul 16, 2026	BUY	Buy -18.6% avg upside 35 analysts	$262.00 20.06% Upside	·
MTB M&T Bank	Jul 16, 2026	HOLD	Buy -12.9% avg upside 27 analysts	$267.00 5.11% Upside	·
BNY Bank of New York Mellon	Jul 16, 2026	BUY	Buy -21.3% avg upside 27 analysts	$178.00 10.66% Upside	+0.0%
BAC Bank of America	Jul 15, 2026	BUY	Strong Buy -15.2% avg upside 46 analysts	$72.00 17.13% Upside	-0.2%
C Citigroup	Jul 15, 2026	BUY	Strong Buy -9.8% avg upside 37 analysts	$154.00 16.91% Upside	·
GS Goldman Sachs Group	Jul 15, 2026	BUY	Buy -21.2% avg upside 32 analysts	$1245.00 13.70% Upside	-7.5%
WFC Wells Fargo	Jul 15, 2026	BUY	Buy -4.6% avg upside 39 analysts	$108.00 22.65% Upside	+0.0%
JPM JPMorgan Chase	Jul 15, 2026	BUY	Strong Buy -22.4% avg upside 46 analysts	$420.00 22.49% Upside	-1.1%
KEY KeyCorp	Jun 25, 2026	HOLD	Strong Buy -1.1% avg upside 29 analysts	$24.00 0.04% Upside	+0.4%
TFC Truist Financial	Jun 25, 2026	SELL	Buy +3.3% avg upside 35 analysts	$56.00 5.11% Upside	-2.5%
FITB Fifth Third Bancorp	Jun 25, 2026	BUY	Strong Buy -10.9% avg upside 30 analysts	$63.00 6.07% Upside	+2.1%
FCNCA First Citizens BancShares	Jun 25, 2026	HOLD	Buy +2.1% avg upside 17 analysts	$2346.00 8.78% Upside	+0.8%
HBAN Huntington Bancshares	Jun 25, 2026	HOLD	Strong Buy +1.5% avg upside 27 analysts	$20.00 7.79% Upside	+1.2%
RF Regions Financial	Jun 25, 2026	SELL	Buy -11.8% avg upside 32 analysts	$30.00 7.41% Downside	-8.1%
STT State Street	Jun 25, 2026	HOLD	Buy -18.4% avg upside 24 analysts	$165.00 11.09% Downside	+8.9%
USB US Bancorp	Jun 25, 2026	BUY	Strong Buy -4.0% avg upside 33 analysts	$67.00 4.68% Upside	+5.6%
ZION Zions Bancorporation National Association	Jun 25, 2026	SELL	Hold -13.1% avg upside 34 analysts	$72.00 1.79% Downside	-4.2%
NTRS Northern	Jun 25, 2026	HOLD	Buy -14.9% avg upside 22 analysts	$176.00 6.71% Downside	+4.3%
ALLY Ally Financial	Jun 25, 2026	HOLD	Strong Buy +4.7% avg upside 28 analysts	$56.00 19.69% Upside	-1.5%
CFG Citizens Financial	Jun 25, 2026	BUY	Strong Buy -4.5% avg upside 25 analysts	$77.00 3.59% Upside	+3.5%
COF Capital One Financial	Sep 17, 2024	HOLD	Strong Buy -3.0% avg upside 40 analysts	$154.00 27.39% Downside	+57.4%
FRCB First Republic Bank	Apr 24, 2023	HOLD	Buy +15695212.5% avg upside 22 analysts	$15.00 1874899.93% Upside	·
RELY Remitly Global	Apr 14, 2023	BUY	Strong Buy -0.8% avg upside 14 analysts	$20.00 20.67% Downside	+10.7%
CYTK Cytokinetics	Apr 03, 2023	BUY	Strong Buy +8.5% avg upside 36 analysts	$58.00 27.75% Downside	+88.1%
AMRX Amneal Pharmaceuticals	Mar 02, 2023	BUY	Strong Buy -2.2% avg upside 18 analysts	$7.00 61.26% Downside	+174.9%
ELAN Elanco Animal Health	Feb 17, 2023	HOLD	Strong Buy +18.1% avg upside 18 analysts	$18.00 30.69% Downside	+23.8%
IDXX Idexx Laboratories	Jan 16, 2023	BUY	Buy +26.5% avg upside 17 analysts	$582.00 1.07% Upside	+8.3%
AMAL Amalgamated Bank	Jan 28, 2022	BUY	Buy -36.8% avg upside 8 analysts	$22.00 54.48% Downside	+41.1%
SICP Silvergate Capital	May 18, 2021	HOLD	Sell +17811.2% avg upside 12 analysts	$135.00 29900.09% Upside	·
AUB Atlantic Union Bankshares	Apr 13, 2021	HOLD	Strong Buy +1.7% avg upside 14 analysts	$43.00 0.63% Downside	-2.0%
EWBC East West Bancorp	Oct 09, 2015	BUY	Strong Buy -16.7% avg upside 24 analysts	$50.00 63.20% Downside	+3.0%
TCBI Texas Capital Bancshares	Apr 26, 2012	HOLD	Hold -17.1% avg upside 23 analysts	$40.00 62.81% Downside	+11.1%
FHN First Horizon	Jul 09, 2010	HOLD	Buy -9.2% avg upside 31 analysts	$15.00 40.94% Downside	-21.8%

🔒 29 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Jason Goldberg — Frequently Asked Questions

How accurate are Jason Goldberg's stock ratings?

Based on the calls 13Foresight could measure, about 73% of Jason's ratings were profitable over a one-year hold, with an average return of +10.1% per rating, or +9.0% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is Jason ranked on 13Foresight?

Jason Goldberg is currently ranked #138 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Jason cover?

Jason most recently has ratings on PNC, MS, MTB, BNY, BAC, C, GS, WFC, JPM, KEY, TFC, FITB and 22 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Rating Distribution

Welcome to 13Foresight!